Blog
About

0
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Should the Hematocrit (Hemoglobin) Be Normalized in Pre-ESRD or Dialysis Patients? Yes!

      ,

      Blood Purification

      S. Karger AG

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Most cited references 1

          • Record: found
          • Abstract: not found
          • Article: not found

          NORMALIZATION OF HEMATOCRIT IN HEMODIALYSIS PATIENTS WITH CARDIAC DISEASE DOES NOT INCREASE BLOOD PRESSURE

            Bookmark

            Author and article information

            Journal
            BPU
            Blood Purif
            10.1159/issn.0253-5068
            Blood Purification
            S. Karger AG
            978-3-8055-7186-9
            978-3-318-00668-1
            0253-5068
            1421-9735
            2001
            2001
            28 December 2000
            : 19
            : 2
            : 168-174
            Affiliations
            Section of Nephrology, Department of Medicine, West Virginia University School of Medicine, Morgantown, W. Va., USA
            Article
            46935 Blood Purif 2001;19:168–174
            10.1159/000046935
            11150804
            © 2001 S. Karger AG, Basel

            Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

            Page count
            Pages: 7
            Product
            Self URI (application/pdf): https://www.karger.com/Article/Pdf/46935
            Categories
            Paper

            Cardiovascular Medicine, Nephrology

            Comments

            Comment on this article